Morgan Stanley analysts have raised their price target for Micron Technology (MU) shares to a record $325 from the previous $220. Experts highlight the sharp surge in DDR5 memory prices, which have tripled over the past month, a level not seen since the 1990s. This creates a unique opportunity for the company to achieve record financial results.
According to forecasts, DRAM prices could rise another 15–20 percent in the first half of 2026, with some transactions reaching as much as 50 percent above benchmark prices. The main driver of this growth is the very strong demand from artificial intelligence data centers, which consume a large portion of global DRAM production. Manufacturers are focusing on producing faster HBM chips for AI, limiting the availability of DDR5 for consumer use.
Analysts note that unlike previous memory shortages, such as in 2018, Micron is entering the current cycle with record profits, allowing the company to operate in uncharted territory in terms of earnings potential. At the same time, production capacity expansion by manufacturers like Samsung and Hynix is accelerating, although demand still exceeds supply.
Despite a 180 percent increase in the stock price this year, experts believe the company still has significant upside due to sustained demand for DRAM and HBM in the AI segment.
Wheat drops amid higher than expected WASDE report
Alibaba sell-off extends amid White House national security concerns📌
US Earnings Season Summary 🗽What the Latest FactSet Data Shows
NATGAS slightly gains after the EIA inventories change report
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.